Epidemiology and prognostic implications of contrast-induced nephropathy. - Wikidata - awgldk - TriplyDB

Epidemiology and prognostic implications of contrast-induced nephropathy.

Epidemiology and prognostic implications of contrast-induced nephropathy.

http://www.wikidata.org/entity/Q34570528

about

Measures used to treat contrast-induced nephropathy: overview of reviews Sildenafil citrate for prophylaxis of nephropathy in an animal model of contrast-induced acute kidney injury Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology.Contrast-induced acute kidney injury in patients undergoing cardiac resynchronization therapy-incidence and prognostic importance. Sub-analysis of data from randomized TRUST CRT trial.Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting.Contrast induced nephropathy in urology.Follow up for emergency department patients after intravenous contrast and risk of nephropathy Optimizing imaging in suspected appendicitis (OPTIMAP-study): a multicenter diagnostic accuracy study of MRI in patients with suspected acute appendicitis. Study Protocol.Functional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy.Extended renal outcomes with use of iodixanol versus iohexol after coronary angiography.Mechanisms for an effect of acetylcysteine on renal function after exposure to radio-graphic contrast material: study protocol.Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.Efficacy of short-term high-dose statin pretreatment in prevention of contrast-induced acute kidney injury: updated study-level meta-analysis of 13 randomized controlled trials Determination of safe contrast media dosage to estimated glomerular filtration rate ratios to avoid contrast-induced nephropathy after elective percutaneous coronary intervention.Contrast-induced acute kidney injury: short- and long-term implications.N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis.The role of neutrophil-gelatinase-associated lipocalin in early diagnosis of contrast nephropathy.Evaluation of a handheld creatinine measurement device for real-time determination of serum creatinine in radiology departments.Impact of biplane versus single-plane imaging on radiation dose, contrast load and procedural time in coronary angioplasty The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively Contrast Induced Nephropathy with Intravenous Iodinated Contrast Media in Routine Diagnostic Imaging: An Initial Experience in a Tertiary Care Hospital.Acute Kidney Injury Risk Prediction in Patients Undergoing Coronary Angiography in a National Veterans Health Administration Cohort With External Validation Contrast Medium Exposure During Computed Tomography and Risk of Development of End-Stage Renal Disease in Patients With Chronic Kidney Disease: A Nationwide Population-Based, Propensity Score-Matched, Longitudinal Follow-Up Study How do centres begin the process to prevent contrast-induced acute kidney injury: a report from a new regional collaborative Comparison of left ventricular ejection fraction values obtained using invasive contrast left ventriculography, two-dimensional echocardiography, and gated single-photon emission computed tomography.The efficacy of the cystatin C based glomerular filtration rate in the estimation of safe contrast media volume.Neutrophil gelatinase-associated lipocalin (NGAL) fails as an early predictor of contrast induced nephropathy in chronic kidney disease (ANTI-CI-AKI study).A clinical study about contrast nephropathy: risk factors and the role of beta blockers Contrast-induced kidney injury: focus on modifiable risk factors and prophylactic strategies.Statins in patients with chronic kidney disease: why, who and when?Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials.Subclinical acute kidney injury (AKI) due to iodine-based contrast media.Contrast-induced acute kidney injury following PCI.Acute kidney injury in China.How to balance risks and benefits in the management of CKD patients with coronary artery disease.Contrast-Induced Acute Kidney Injury: An Update.Impact of Iodinated Contrast on Renal Function and Hemodynamics in Rats with Chronic Hyperglycemia and Chronic Kidney Disease.Reducing Acute Kidney Injury Due to Contrast Material: How Nurses Can Improve Patient Safety Hyperuricemia Is an Independent Predictor of Contrast-Induced Acute Kidney Injury and Mortality in Patients Undergoing Percutaneous Coronary Intervention.Preliminary investigation of the dissolution behavior, cytocompatibility, effects of fibrinogen conformation and platelet adhesion for radiopaque embolic particles.

P2860

Q26849704-78961965-A221-4EFD-A9C7-E224AABB2172 Q28545221-92B12584-3A1D-44E6-BE5D-FB59157C4E65 Q30439077-F6B6AF8E-4998-466F-882E-61310FC6CB12 Q30777142-280757A0-9275-408B-8902-07B76A381851 Q33571334-0BD41501-9D5F-4A9D-B618-4CFEAD005EFA Q33599720-8B9D6B42-0BAF-465F-9ECA-263F881D8B87 Q33629728-360741FB-AC86-4A5A-8383-FFC4D4C8604C Q33723467-70FC4F57-431D-487F-BE33-8C5663371DD8 Q33862673-E199C976-9F01-432B-85EA-AC5DE42500C3 Q34080177-2920D31E-A233-4D43-8EDB-B00F7E4F02BF Q34150613-DA67437C-66CD-40D7-BB9C-3E606C7C3A43 Q34437133-685811B2-8CE8-41FB-BEBD-BC364B282962 Q34450309-E4C3424B-ADB5-4EFF-913E-75444764969E Q35048384-D44736C7-4F8A-419D-A5F4-B23CF56FFE27 Q35127308-BBDD2FC1-60B6-4000-B754-AC021E75184D Q35803600-AEF56A6E-70A6-49AE-B245-D09DDA99917E Q36106130-4B2E73D5-F3E6-4436-81BE-B8FD2175A2A5 Q36166567-9B847D11-E6EE-4C06-AFD1-2F213DAC22E4 Q36324396-4EA2C8F5-8ED7-4675-B5B8-7B0DFE2D8F55 Q36376516-8903BE0D-7CC8-4CFE-8BE2-AD4D05384DA8 Q36741996-7E6DC42B-5530-4DEC-A527-435FD1787EE8 Q36836473-1036E28D-ED34-4FC5-9275-4C83D3EEC685 Q36838026-35FEC54F-B190-4649-B290-0A3709801A16 Q36915662-123B0BDC-F78D-403F-AFFC-1ADBAE58509D Q37221883-274F98E7-0205-406B-9073-3342CC7DCD4E Q37256685-3EDA5E0A-A81F-4309-82F4-63D5BF4AE146 Q37609407-55DF9C8E-3875-4C3D-A7FD-344308F38238 Q37680682-5F250E7F-532B-484E-88EF-F9614B25536D Q37699097-B26F65E8-ADDC-4057-AC15-21CCF2C01ED5 Q37803236-0A1FA3F8-1F82-4FD8-B8C3-1955EF464075 Q37864718-AD143869-E02C-424D-ABC4-FAF70D214435 Q38034918-13CB82B3-AABD-4542-95B7-42311D6EA16B Q38084715-181C406A-1C7B-4FFF-A4DD-26D53C64BB17 Q38232813-6288DDAB-7400-4F3E-A820-4DE93CFD8BBF Q38364890-4289CCB2-4035-49ED-B005-26A6E764BC16 Q38701320-8DD7B8EC-F94F-4A5A-BA11-2018C5141691 Q38961666-E3505DCF-B363-4927-8082-71F70AF7A5B9 Q38985809-5E5C14E5-B596-44BD-B4F2-8456F025B5BB Q39036982-4ABA00BD-50D9-4BC7-91D5-CB55AFC33E00 Q39870276-0CE3E004-EEDF-4C9F-90D8-83F5B054D001

P2860

Epidemiology and prognostic implications of contrast-induced nephropathy.

http://www.wikidata.org/entity/Q34570528

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Epidemiology and prognostic implications of contrast-induced nephropathy.

@ast

Epidemiology and prognostic implications of contrast-induced nephropathy.

@en

Epidemiology and prognostic implications of contrast-induced nephropathy.

@nl

type

label

Epidemiology and prognostic implications of contrast-induced nephropathy.

@ast

Epidemiology and prognostic implications of contrast-induced nephropathy.

@en

Epidemiology and prognostic implications of contrast-induced nephropathy.

@nl

prefLabel

Epidemiology and prognostic implications of contrast-induced nephropathy.

@ast

Epidemiology and prognostic implications of contrast-induced nephropathy.

@en

Epidemiology and prognostic implications of contrast-induced nephropathy.

@nl

P1433

Q34570528-54BED8DC-9212-4344-BE89-A8EE7386E67A

P1476

Q34570528-340D0ADB-32E6-4B4A-8178-35B38836C9BB

P2093

Q34570528-15F38421-FB92-4E01-B42A-E20F8F2E80FE

Q34570528-3F98AE30-1D90-4978-B9C6-3BBF81E33FA4

Q34570528-992B1072-4FB3-490A-8516-6F8BA84A7116

Q34570528-9D110BCD-5708-48F2-ACEB-C40D559CA98D

Q34570528-B95A1A15-40D4-48A5-B875-CD7EC89F042D

Q34570528-DBAB5750-B860-4694-A246-C0403CB492C2

Q34570528-EB78A304-A81E-4D74-8EBB-FF777F86B7AB

Q34570528-F5B8FD87-1744-4FEB-872F-D61A351AED9C

P304

Q34570528-647C8373-7C0A-4426-96C4-E9E1E73364FE

P31

Q34570528-A335AD32-B1FC-45BC-8243-7EC8A181D835

P356

Q34570528-DFDCE5AA-90D9-4ACF-9E1B-15CB7110D114

P407

Q34570528-8B5459DA-C741-4160-9531-B038F54EE9B7

P433

Q34570528-42A7E50E-CF88-4904-BFEB-08C19084BE55

P478

Q34570528-5517C8F9-CABE-48D1-99FB-39CB1FF36D25

P577

Q34570528-8D1FD854-D0FE-4EB6-AC23-0D0596574174

P698

Q34570528-2909D8AE-F0D0-4A5F-BEEC-E6FFA5E7B159

P921

Q34570528-3DDE2A00-2AE1-4D69-B297-F3E8F8126563

P356

J.AMJCARD.2006.01.019

P1433

American Journal of Cardiology

P1476

Epidemiology and prognostic implications of contrast-induced nephropathy.

@en

P2093

Andy Adam

http://www.w3.org/2001/XMLSchema#string

CIN Consensus Working Panel

http://www.w3.org/2001/XMLSchema#string

Charles Davidson

http://www.w3.org/2001/XMLSchema#string

Christoph R Becker

http://www.w3.org/2001/XMLSchema#string

Fulvio Stacul

http://www.w3.org/2001/XMLSchema#string

James Tumlin

http://www.w3.org/2001/XMLSchema#string

Norbert Lameire

http://www.w3.org/2001/XMLSchema#string

Peter A McCullough

http://www.w3.org/2001/XMLSchema#string

P304

5K-13K

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AMJCARD.2006.01.019

http://www.w3.org/2001/XMLSchema#string

P407

P433

6A

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2006-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16949375

http://www.w3.org/2001/XMLSchema#string

P921